Filing Details

Accession Number:
0001437749-22-016970
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-11 18:40:08
Reporting Period:
2022-07-07
Accepted Time:
2022-07-11 18:40:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1213809 Dyadic International Inc DYAI Biological Products, (No Disgnostic Substances) (2836) 450486747
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1761230 Ronen Tchelet C/O Dyadic International, Inc.
140 Intracoastal Pointe Drive Suite 404
Jupiter FL 33477-5094
Vp Of Research And Bus. Dvlpmt No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-07-07 7,854 $1.57 7,854 No 4 M Direct
Common Stock Disposition 2022-07-07 7,854 $3.50 0 No 4 S Direct
Common Stock Acquisiton 2022-07-08 1,089 $1.57 1,089 No 4 M Direct
Common Stock Disposition 2022-07-08 1,089 $3.41 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2022-07-07 7,854 $0.00 7,854 $1.57
Common Stock Stock Option Disposition 2022-07-08 1,089 $0.00 1,089 $1.57
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
42,146 2017-01-19 2026-01-18 No 4 M Direct
41,057 2017-01-19 2026-01-18 No 4 M Direct
Footnotes
  1. The sale of the shares of Class A Common Stock was the last transaction made pursuant to Rule 10b5-1 trading plan adopted on May 31, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a range of $3.41 to $3.55, inclusively. Thereporting person undertakes to provide to Dyadic International, Inc., any security holder of Dyadic International, Inc., or the staff of the Securities and ExchangeCommission, upon request, full information regarding the number of footnote (1) to this Form 4.